Over the past 12 months, 2 insiders at Health Catalyst, Inc. filed 3 open-market SEC Form 4 transactions on HCAT: 0 purchases worth $0 and 3 sales worth $221K. Insiders have been net sellers over this period. The most recent filing was on Dec 5, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 5, 25 | Benjamin LandryGeneral Counsel | SELL | 27.4K | $2.64 | $72K |
| Dec 4, 25 | Julie Larson-greenDirector | SELL | 48.0K | $2.67 | $128K |
| Sep 5, 25 | Benjamin LandryGeneral Counsel | SELL | 6.2K | $3.35 | $21K |
| Jun 5, 25 | Benjamin LandryGeneral Counsel | SELL | 6.1K | $3.94 | $24K |
| May 5, 25 | Daniel LesueurChief Operating Officer | SELL | 5.2K | $4.10 | $21K |
| Apr 3, 25 | Daniel LesueurChief Operating Officer | SELL | 5.2K | $4.15 | $22K |
| Mar 6, 25 | Benjamin LandryGeneral Counsel | SELL | 13.8K | $4.55 | $63K |
| Mar 5, 25 | Daniel LesueurChief Operating Officer | SELL | 16.9K | $4.52 | $76K |
| Feb 18, 25 | Linda LlewelynChief People Officer | SELL | 6.4K | $5.43 | $35K |
| Feb 5, 25 | Daniel LesueurChief Operating Officer | SELL | 5.2K | $5.76 | $30K |
| Jan 15, 25 | Linda LlewelynChief People Officer | SELL | 6.4K | $5.80 | $37K |
| Jan 6, 25 | Benjamin LandryGeneral Counsel | SELL | 2.5K | $7.52 | $19K |
| Jan 6, 25 | Daniel LesueurChief Operating Officer | SELL | 5.2K | $7.51 | $39K |
| Dec 30, 24 | Duncan GallagherDirector | SELL | 4.5K | $6.93 | $31K |
| Dec 23, 24 | Duncan GallagherDirector | SELL | 4.5K | $6.98 | $31K |
| Dec 16, 24 | Linda LlewelynChief People Officer | SELL | 6.4K | $7.88 | $51K |
| Dec 6, 24 | Jason AlgerChief Financial Officer | SELL | 19.6K | $8.32 | $163K |
| Dec 6, 24 | Benjamin LandryGeneral Counsel | SELL | 19.3K | $8.32 | $160K |
| Dec 4, 24 | Daniel LesueurChief Operating Officer | SELL | 22.8K | $7.70 | $175K |
| Dec 2, 24 | Kevin Lee FreemanChief Commercial Officer | SELL | 7.5K | $8.94 | $67K |
| Nov 15, 24 | Linda LlewelynChief People Officer | SELL | 1.4K | $8.50 | $12K |
| Nov 5, 24 | Daniel LesueurChief Operating Officer | SELL | 5.2K | $7.70 | $40K |
| Oct 15, 24 | Linda LlewelynChief People Officer | SELL | 1.3K | $8.16 | $11K |
| Oct 3, 24 | Daniel LesueurChief Operating Officer | SELL | 5.2K | $7.68 | $40K |
| Sep 16, 24 | Linda LlewelynChief People Officer | SELL | 1.3K | $8.43 | $11K |
| Sep 6, 24 | Jason AlgerChief Financial Officer | SELL | 2.9K | $7.39 | $21K |
| Sep 6, 24 | Benjamin LandryGeneral Counsel | SELL | 2.5K | $7.39 | $18K |
| Sep 4, 24 | Daniel LesueurChief Operating Officer | SELL | 8.1K | $7.58 | $62K |
| Sep 3, 24 | Kevin Lee FreemanChief Commercial Officer | SELL | 7.5K | $7.22 | $54K |
| Aug 15, 24 | Linda LlewelynChief People Officer | SELL | 1.3K | $6.57 | $9K |
| Aug 5, 24 | Daniel LesueurChief Operating Officer | SELL | 5.2K | $6.19 | $32K |
| Jul 15, 24 | Linda LlewelynChief People Officer | SELL | 1.3K | $6.51 | $8K |
| Jul 3, 24 | Daniel LesueurChief Operating Officer | SELL | 5.2K | $6.15 | $32K |
| Jun 17, 24 | Linda LlewelynChief People Officer | SELL | 1.3K | $6.37 | $8K |
| Jun 12, 24 | Jason AlgerChief Financial Officer | SELL | 2.8K | $6.83 | $19K |
| Jun 11, 24 | Kevin Lee FreemanChief Commercial Officer | SELL | 7.5K | $6.53 | $49K |
| Jun 6, 24 | Benjamin LandryGeneral Counsel | SELL | 2.4K | $6.71 | $16K |
| Jun 6, 24 | Daniel LesueurChief Operating Officer | SELL | 11.9K | $6.72 | $80K |
| May 31, 24 | Benjamin LandryGeneral Counsel | SELL | 12.6K | $6.61 | $83K |
| May 15, 24 | Linda LlewelynChief People Officer | SELL | 2.1K | $7.00 | $14K |
| Apr 15, 24 | Linda LlewelynChief People Officer | SELL | 2.0K | $6.11 | $12K |
| Mar 15, 24 | Linda LlewelynChief People Officer | SELL | 2.0K | $7.80 | $16K |
| Feb 27, 24 | Daniel D. BurtonChief Executive Officer | BUY | 26.2K | $7.81 | $205K |
| Feb 15, 24 | Linda LlewelynChief People Officer | SELL | 3.3K | $9.77 | $32K |
| Jan 16, 24 | Linda LlewelynChief People Officer | SELL | 3.2K | $10.83 | $34K |
| Dec 15, 23 | Linda LlewelynChief People Officer | SELL | 3.2K | $8.83 | $28K |
| Dec 6, 23 | Jason AlgerChief Accounting Officer | SELL | 2.2K | $7.55 | $16K |
| Nov 15, 23 | Linda LlewelynChief People Officer | SELL | 1.2K | $8.25 | $10K |
| Oct 16, 23 | Linda LlewelynChief People Officer | SELL | 1.2K | $8.33 | $10K |
| Sep 15, 23 | Linda LlewelynChief People Officer | SELL | 1.2K | $11.01 | $13K |
Over the past 12 months, insiders at Health Catalyst, Inc. filed 0 open-market purchases worth $0 and 3 sales worth $221K on HCAT, which makes them net sellers over the period. The most recent Form 4 was filed on Dec 5, 25.
The largest recent open-market HCAT insider purchase in our data was $205K by Daniel D. Burton, Chief Executive Officer, filed on Feb 27, 24.
2 different insiders at Health Catalyst, Inc. filed open-market SEC Form 4 transactions on HCAT over the last 12 months.
InsiderTape plots every HCAT insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Health Catalyst, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →